While global harmonization exists, there are still differences between the US and European GMP requirements that ...

The pharma industry is focused on strengthening its foundation, embracing innovation, and future-proofing its path forward.

How BioDuro is expanding its global CRDMO footprint by improving integrated capabilities and delivering high-quality, ...

Aviva Capital Partners and developer Socius are investing £1 billion to develop a cancer research and treatment center in Sutton, London. On May 1, 2025, Aviva Capital Partners and mixed-use developer ...

Donald Ingber, MD, PhD; Miguel Forte, MD, PhD; Ali Pashazadeh, MRCS, MBA; and Adam Inche, PhD, MBA go behind the headlines to ...

The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

How Lonza Capsules & Health Ingredients (CHI) is redefining drug delivery with cutting-edge capsule innovation, ...